Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q Source: Seekingalpha
Browsing: Healthcare
Gilnature/iStock by way of Getty Images Pharmaceutical firm ARCA biopharma (NASDAQ:ABIO) stated on Friday its board has accredited a reverse stock split of its shares at…
Trials for psychedelic drug candidate for PTSD under scrutiny by FDA – report Source: Seekingalpha
JP Yim The head of the World Health Organization (WHO) has stated that a global response plan to fight the continuing mpox outbreak would require roughly…
Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business targeted on producing radioactive chemical compounds for…
travellinglight/iStock through Getty Images Shortly after a U.Okay. watchdog declined to endorse Biogen’s (NASDAQ:BIIB) Alzheimer’s drug Leqembi to be used within the nation’s nationwide well being…
U.Ozel.Images/E+ by way of Getty Images Although different corporations are poised to have GLP-1 receptor agonist medication for weight loss accredited, they don’t seem to be…
ImmunoPrecise Antibodies (NASDAQ:IPA) obtained a written notification from Nasdaq, notifying them that they don’t adjust to the minimal bid worth requirement outlined within the Nasdaq Listing…
Dexcom (NASDAQ:DXCM) mentioned on Monday its over-the-counter glucose biosensor Stelo is now available for buy in the U.S. Stelo is designed to assist individuals, 18 years…
JHVEPhoto BeiGene (NASDAQ:BGNE) has acquired FDA Fast Track Designation for its investigational cancer therapy. BGB-16673, an orally accessible BTK-targeting chimeric degradation activation compound, gained fast track…